Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Storm

Showing results (61-70 of 392) with videos related to

Pageof 40
Sort By:
Cancer Treatment Reviews|November 13, 2013
Liposomal nanomedicines in the treatment of prostate cancerJan Kroon, Josbert M Metselaar, Gert Storm, et al.
Current Medicinal Chemistry|May 24, 2019
Anti-Inflammatory Properties of Plant Derived Natural Products - A Systematic ReviewIris E Allijn, René P Brinkhuis, Gert Storm, et al.
The British Journal of Ophthalmology|October 31, 2020
A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammationChee Wai Wong, Josbert M Metselaar, Gert Storm, et al.
International Journal of Pharmaceutics|January 25, 2015
Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetrationNoboru Sasaki, Clemens Bos, Jean-Michel Escoffre, et al.
Pharmaceutical Research|April 3, 2003
Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugateMaría José Fonseca, Joycelyn C Jagtenberg, Hidde J Haisma, et al.
Accounts of Chemical Research|May 7, 2011
Theranostic nanomedicineTwan Lammers, Silvio Aime, Wim E Hennink, et al.
Current Opinion in Biotechnology|April 13, 2013
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applicationsLarissa Y Rizzo, Benjamin Theek, Gert Storm, et al.
Drug Discovery Today|February 22, 2021
A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune systemAlexandros Marios Sofias, Francis Combes, Steffen Koschmieder, et al.
Nanotheranostics|January 9, 2020
FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumorDeby Fajar Mardhian, Aggelos Vrynas, Gert Storm, et al.
Nanomedicine (London, England)|August 25, 2007
Synthetic delivery systems for intravenous administration of nucleic acidsRaymond M Schiffelers, Holger K de Wolf, Inge van Rooy, et al.
Pageof 40

Showing results (61-70 of 392) with videos related to

Sort By:
Pageof 40
Cancer Treatment Reviews|November 13, 2013
Liposomal nanomedicines in the treatment of prostate cancerJan Kroon, Josbert M Metselaar, Gert Storm, et al.
Current Medicinal Chemistry|May 24, 2019
Anti-Inflammatory Properties of Plant Derived Natural Products - A Systematic ReviewIris E Allijn, René P Brinkhuis, Gert Storm, et al.
The British Journal of Ophthalmology|October 31, 2020
A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammationChee Wai Wong, Josbert M Metselaar, Gert Storm, et al.
International Journal of Pharmaceutics|January 25, 2015
Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetrationNoboru Sasaki, Clemens Bos, Jean-Michel Escoffre, et al.
Pharmaceutical Research|April 3, 2003
Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugateMaría José Fonseca, Joycelyn C Jagtenberg, Hidde J Haisma, et al.
Accounts of Chemical Research|May 7, 2011
Theranostic nanomedicineTwan Lammers, Silvio Aime, Wim E Hennink, et al.
Current Opinion in Biotechnology|April 13, 2013
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applicationsLarissa Y Rizzo, Benjamin Theek, Gert Storm, et al.
Drug Discovery Today|February 22, 2021
A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune systemAlexandros Marios Sofias, Francis Combes, Steffen Koschmieder, et al.
Nanotheranostics|January 9, 2020
FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumorDeby Fajar Mardhian, Aggelos Vrynas, Gert Storm, et al.
Nanomedicine (London, England)|August 25, 2007
Synthetic delivery systems for intravenous administration of nucleic acidsRaymond M Schiffelers, Holger K de Wolf, Inge van Rooy, et al.
Pageof 40